secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edwards Lifesciences Corp (EW)
CIK:        0001099800
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001099800-25-000026
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edwards shareholders approve 5.66M new shares for employee stock purchase plans
-------------------------------------------------------------------------------

- Shareholders approved US ESPP amendment adding 4.2M shares and International ESPP adding 1.46M shares.
- All nine director nominees elected with strong support; lowest was Paul LaViolette at 92.3% for.
- Advisory say-on-pay proposal passed with 88.0% of votes cast in favor.
- Ratification of PwC as auditor for FY2025 approved with 89.9% for.
- Broker non-votes present on all proposals except auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1099800/000109980025000026/0001099800-25-000026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1099800/000109980025000026/ew-20250508.htm
  HTML page:      https://secwatch.observer/filing/0001099800-25-000026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer